Clinical Trial Update: Naloxegol Health Outcome Post Authorisation Safety Study

View source ↗

Summary

A post-authorization safety study of naloxegol for opioid-induced constipation sponsored by Kyowa Kirin Pharmaceutical Development Ltd has been terminated; no r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• Naloxegol (naloxegol)

Snippet

Sponsor: Kyowa Kirin Pharmaceutical Development Ltd | Conditions: Opioid Induced Constipation | Status: TERMINATED